Business Roundtable
FDA/Regulatory: FDA Reforms to Speed Innovative Drugs to Market
Wednesday, February 15, 2006
8:30 AM
Conrad Suite
The FDA has proposed reforms to speed innovative new drugs to market. Is this the beginning of a new era at the FDA where innovative drugs are given top priority? And, if so, how will this impact the biotechnology industry where innovation is the driver? This panel of insiders, former insiders and experienced observers will share their insight on this critical issue.
Moderators
- Paul De Stefano; Principal, Fish & Richardson P.C.
Panelists
- Steve Usdin; Washington Editor, BioCentury Publications Inc.
- Amit Sachdev; Executive Vice President, Health, Biotechnology Industry Organization
- Scott Gottlieb, MD; Deputy Commissioner for Medical and Scientific Affairs, U.S. Food and Drug Administration
- Robert Goldberg; Senior Fellow and the Director of the Center for Medical Progress, Manhattan Institute for Policy Research